Dr. Kemi Doll awarded grant from PCORI for The SISTER Study
Dr. Kemi Doll's project, Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence -- The SISTER Study, "is the first national randomized trial to focus on improving outcomes for Black/African-American (AA) women with endometrial cancer (EC)."
Mission: We work to understand who is at elevated risk for ovarian cancer, and how we can treat specific mutations and genetic alterations to improve outcomes. Our research has led to an improved understanding of how genomics, immunology, and molecular biology impact gynecologic cancers. One-size-fits-all chemotherapy and radiation treatments may one day be a thing of the past.
- Transformative work to identify modifiable factors in endometrial cancer racial inequity
- Early detection of ovarian cancer through symptom recognition
- Novel treatments of ovarian cancer
Meet the Principal Investigators
Kemi Doll, MD, MSCR
Research Interests: health equity, endometrial cancer, hysterectomy, community engaged research, population level analysis, patient reported outcomes
Research Networks: ECANA, UNC Carolina Hysterectomy Cohort
Barbara Goff, MD
Research Interests: early detection of ovarian cancer, novel treatments for ovarian cancer based on personalized functional genomics, management of treatment related side effects in women with ovarian cancer
Research Centers & Networks: NICHD K12 Training Grant, NCI Cancer Target Discovery and Development, National Comprehensive Cancer Network
Elizabeth Swisher, MD
Research Interests: Genetics, personalized therapy for gynecologic cancers, harnessing DNA repair defects to treat cancers, ovarian cancer prevention and early detection, genomics and predictors of response to therapy, clinical trials
Research Centers & Networks: